Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Herbal cancer cure claims

This article was originally published in The Tan Sheet

Executive Summary

David Walker, d/b/a DLW Consulting, permanently barred from representing dietary supple-ments, devices as "effective in treating and curing cancer" or as making "surgery, chemotherapy and other conventional cancer treatments unnecessary" absent competent and reliable scientific evidence, according to stipulated judgment signed by Tacoma, Wash. federal judge Oct. 23. In case brought by FTC, Walker also is required to turn over to commission customers' names, addresses; judgment includes monetary penalty if Walker made "material misrepresentations or omissions" in his financial disclosure form. FTC sued Walker in March related to cancer claims for CWAT-Treatment: BioResonance Therapy, which included dietary supplements (1"The Tan Sheet" April 8, 2002, p. 14). 2FTC press release notes Walker was required to pay $229,000 in consumer restitution under companion case brought by Washington AG...

David Walker, d/b/a DLW Consulting, permanently barred from representing dietary supple-ments, devices as "effective in treating and curing cancer" or as making "surgery, chemotherapy and other conventional cancer treatments unnecessary" absent competent and reliable scientific evidence, according to stipulated judgment signed by Tacoma, Wash. federal judge Oct. 23. In case brought by FTC, Walker also is required to turn over to commission customers' names, addresses; judgment includes monetary penalty if Walker made "material misrepresentations or omissions" in his financial disclosure form. FTC sued Walker in March related to cancer claims for CWAT-Treatment: BioResonance Therapy, which included dietary supplements (1 (Also see "Herbal Cancer Cure One Of 63 Scams Targeted By FTC Internet Initiative" - Pink Sheet, 8 Apr, 2002.), p. 14). 2 FTC press release notes Walker was required to pay $229,000 in consumer restitution under companion case brought by Washington AG....

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094730

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel